International Assets Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

International Assets Investment Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,375	Closed	-$2K	–	2221
2021 Q1	$2K	Hold	2,375	–	–	﹤0.01%	2071
2020 Q4	$2K	Buy	+2,375	New	+$5.06K	﹤0.01%	1951

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

International Assets Investment Management's BMY.RT Position: Q2 2021 in Review

International Assets Investment Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2021, closing a stake of 2,375 shares — an estimated $2K sold.

International Assets Investment Management first reported a position in BMY.RT in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 8 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2021.

International Assets Investment Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2021 after selling out during the quarter.
International Assets Investment Management sold 2,375 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2021, an estimated $2K.
International Assets Investment Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 2 quarters.
International Assets Investment Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2K in Q1 2021.
8 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.